Skip to content

Replimune Group REPL Return on invested capital

Return on invested capital at other companies

Amgen logo
AmgenAMGN
14.1%+4.0pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
10.3%-2.0pp
Immunome logo
ImmunomeIMNM
-746.6%+212pp
CG Oncology logo
CG OncologyCGON
-24.9%+1.8pp
Erasca, Inc. logo
Erasca, Inc.ERAS
-75.9%+17.2pp
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-51.8%-3.3pp

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+30.2%
Enterprise value$885.15M+30.0%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Calculated from Replimune Group’s reported figures.

Based on trailing twelve months.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's return on invested capital?
Replimune Group (REPL) reported return on invested capital of -118% in Q4 2025.
How has Replimune Group's return on invested capital changed year-over-year?
Replimune Group's return on invested capital decreased by 92.9% year-over-year, from -61.2% to -118%.
What is the long-term trend for Replimune Group's return on invested capital?
Over 4 years (2021 to 2025), Replimune Group's return on invested capital has grown at a 22.2% compound annual growth rate (CAGR), from -30.9% to -68.9%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.